Oaktree Acquisition Corp. III Life Sciences
Searching since IPO 2024-10-24- CIK 2029769
- OACC
- IPO 2024-10-24
- $205M trust
- 65 filings
- IPO Size
- $175M
- raised at the IPO
- Trust
- $205M
- as of 2026-06-30
- Current Status
- Unit Split
- from its latest filing
- IPO Year
- 2024
- year it listed
Filings, by quarter
65 filings over 10 quarters; violet bars carry a milestone
- 24 Q3: 4 filings
- 24 Q4: 27 filings
- 25 Q1: 4 filings
- 25 Q2: 7 filings
- 25 Q3: 3 filings
- 25 Q4: 5 filings
- 26 Q1: 2 filings
- 26 Q2: 3 filings
- 26 Q3: 4 filings
- 26 Q4: 6 filings
- S-1 filed 24 Q3
- IPO 24 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Oaktree Acquisition Corp. III Life Sciences is a blank-check company seeking an initial business combination, with an intended focus on healthcare and healthcare-related industries, especially biopharmaceuticals, medical devices, diagnostics and specialized healthcare services.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
North America, United Kingdom, Western Europe
Key Information
As the filings state it
- IPO Date
- 2024-10-24
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- SPAC Ticker
- OACC
Stock Performance
OACCUTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2024-10-24 | $10.00 | |
| Current Price | 2026-10-23 | $10.80 | +8% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team includes senior Oaktree investment and operating professionals with healthcare and life-sciences investing experience, alongside leaders with backgrounds in finance, investment banking, medicine, drug development and prior SPAC business combinations.